Delivery Order SPE2DB22D2103-SPE2DB25FR9NN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,942.94 to AmerisourceBergen Drug Corp for the supply of esomeprazole magnesium delayed-release 40 mg capsules (30-count units). This order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Esomeprazole Magnesium Delayed Release 40 mg capsules (30-count unit) with a ceiling value of $1,599.84. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competitive procurement. The order is set for ultimate completion by July 31, 2025, and will be performed at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) with a ceiling value of $12,297.40. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract performance location is in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, with an ultimate completion date of July...
- The Defense Logistics Agency awarded a $1,066.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count units). This non-competitive, non-set-aside delivery order is scheduled for completion by July 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) with a contract value of $1,660.95. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a non-competitive set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under...
- The Defense Logistics Agency awarded a delivery order valued at $2,916.54 to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 20 mg capsules (90-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,533.09 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) on August 7, 2025, with completion targeted for August 8, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,858.83 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count unit). This is a firm fixed-price contract with an ultimate completion date of July 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating the contract was competitively awarded. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Esomeprazole Magnesium Delayed Release 20 mg capsules (90-count) with a ceiling value of $19,515.80. This firm fixed price, non-set-aside delivery order is scheduled for completion by August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply under the company's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) with a ceiling value of $1,199.22. This contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for ultimate completion by July 31, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB22D2103Indefinite Delivery Contract
- SPE2DB22D2103-SPE2DB25FR9NNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 40 mg capsules (30-count) on July 23, 2025, with a ceiling value of $1,713.18 and completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This comprehensive prime vendor contract serves as the primary vehicle through which AmerisourceBergen supplies pharmaceutical products and medical commodities to support military healthcare systems and the Defense Health Agency globally. The IDC encompasses a diverse portfolio of medications, vaccines, medical devices, and specialized healthcare supplies across multiple therapeutic domains, enabling the company to fulfill federal medical procurement requirements for both routine and specialized pharmaceutical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/23/25 |